Mid-Year Report

THE MCMANUS GROUP for ELI LILLY AND COMPANY

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2900/S. 1082, Prescription Drug User Fee Act reauthorization Support for Cochran amendment to PDUFA reauthorization

LobbyistCovered position, as disclosed
JOHN MCMANUS N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1082 (110th), H.R. 2900 (110th)

Medicare/Medicaid MMM

Opposition to non-interference repeal in H.R. 4/S. 3, "Medicare Prescription Drug Price Negotiation Act of 2007." Opposition to increased Medicaid rebates

LobbyistCovered position, as disclosed
JOHN MCMANUS N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3 (110th), H.R. 4 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.